Cardiac autonomic function and insulin resistance for the development of hypertension: a six-year epidemiological

J S Wu1, Y C Yang, F H Lu

  • 1Department of Family Medicine, College of Medicine, National Cheng Kung University, Taiwan, ROC; Department of Family Medicine, National Cheng Kung University Hospital, Taiwan, ROC.

Insights

Cardiac autonomic function, specifically sympathovagal imbalance with reduced parasympathetic tone, predicts new-onset hypertension. Insulin resistance did not independently predict hypertension when autonomic function was considered.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Research
  • Metabolic Syndrome Studies

Background:

  • Cardiac autonomic function (CAF) and insulin resistance (IR) are implicated in cardiovascular health.
  • Understanding their independent and combined roles in hypertension development is crucial.

Purpose of the Study:

  • To investigate the impact of cardiac autonomic function and insulin resistance on the incidence of hypertension.
  • To determine if autonomic dysfunction or insulin resistance is a stronger predictor of new-onset hypertension.

Main Methods:

  • Longitudinal study involving 1638 participants at baseline (1996) and 959 at follow-up (2003).
  • Assessment of cardiac autonomic function using heart rate variability (SDNN, LF, HF, LF/HF ratio, E/I ratio) and time-domain measures.
  • Evaluation of insulin resistance using homeostasis model assessment (HOMA-IR and HOMA-B).

Main Results:

  • In multivariate analysis, insulin resistance (square root of HOMA-IR) was associated with incident hypertension.
  • This association disappeared after adjusting for baseline cardiac autonomic function.
  • Specific measures of sympathovagal imbalance, including LF/HF ratio, HF power, and E/I ratio, were independently associated with incident hypertension.

Conclusions:

  • Sympathovagal imbalance, characterized by decreased parasympathetic tone, is a significant independent predictor of incident hypertension.
  • Cardiac autonomic dysfunction, rather than insulin resistance, appears to be a more critical factor in the development of hypertension in this cohort.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...